GlassScriptPhysician profile
Gene C Kim
NPI 1194732925
$25,140.66
in general payments reported to CMS, 2019-2025
35 companies · $3,179 in 2025
The $3,179 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,970 · 2020: $3,174 · 2021: $7,145 · 2022: $2,777 · 2023: $2,419 · 2024: $1,477 · 2025: $3,179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,606 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,605.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,468.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,630.66 | 2019-2025 | General - Ep, Rhythmia Mapping System, Farapulse |
| Medtronic, INC. | $1,628.82 | 2021-2025 | Micra, Pulseselect, Na |
| Medtronic Vascular, INC. | $679.76 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $610.91 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $495.85 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $352.24 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $292.58 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Cardiva Medical, INC. | $284.50 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Savvywire |
| Abbott Laboratories | $232.61 | 2019-2024 | Ultreon |
| Pfizer INC. | $202.07 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.63 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $182.11 | 2019-2022 | |
| Amgen INC. | $175.01 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $172.58 | 2022-2025 | Camzyos, Eliquis |
| Acutus Medical, INC. | $140.64 | 2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $130.21 | 2019-2021 | |
| Novo Nordisk INC | $107.17 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $89.80 | 2023-2025 | Amvuttra |
| Kestra Medical Technology Services, INC. | $84.98 | 2023-2025 | Assure Wcd |
| Biotronik INC. | $59.98 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.91 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $39.62 | 2022 | |
| Amarin Pharma, INC. | $35.23 | 2019 | |
| Stryker Corporation | $34.99 | 2019 | |
| Zoll Circulation INC | $30.00 | 2023 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Actelion Pharmaceuticals US, INC. | $28.16 | 2023 | Uptravi, Opsumit |
| Kiniksa Pharmaceuticals, LTD. | $25.08 | 2023 | Arcalyst |
| Bausch Health US, LLC | $24.92 | 2023 | Aplenzin |
| Scpharmaceuticals INC. | $24.01 | 2025 | |
| Abiomed | $23.52 | 2019 | |
| Merck Sharp & Dohme LLC | $21.93 | 2023 | Verquvo |
| Esperion Therapeutics, INC. | $21.21 | 2024 | Nexletol |
| Teleflex LLC | $20.16 | 2020 | |
| Terumo Medical Corporation | $17.37 | 2022 | |
| Ge Healthcare | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.